| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |